- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Measuring Success and Real-World Outcomes for MASH
Panelists discuss how defining and tracking meaningful real-world outcomes ensures accountability and value in MASH management.
EP: 1.Understanding the Metabolic–Hepatic Connection in MASH
EP: 2.Enhancing Early Detection and Diagnosis in MASH
EP: 3.Recognizing Risk and the Broader Health Impact in MASH
EP: 4.Evidence for GLP-1 Therapy in MASH
EP: 5.Expanding the Therapeutic Horizon in MASH
EP: 6.Balancing Clinical and Economic Considerations in Treatment Adoption
EP: 7.Identifying and Managing MASH Patients at Risk for Fibrosis
EP: 8.Coordinating Care Across the MASH Continuum
EP: 9.Measuring Success and Real-World Outcomes for MASH
Panelists discuss how success in MASH management should be measured through both clinical and economic outcomes. They propose tracking fibrosis regression, hospitalization rates, and patient quality of life as core metrics.
They also explore employer and payer perspectives, focusing on how reduced absenteeism and improved productivity contribute to overall return on investment for liver health programs.
The discussion closes with a call for longitudinal data collection to evaluate interventions’ real-world effectiveness and refine future practice guidelines.
Knowledge Gaps Persist in Patient Understanding of Skin Cancer–Related Terms
January 13th 2026On average, patients with multiple prior dermatology visits still scored below 75% when identifying common skin cancer terms, underscoring the need for clearer patient-physician communication.
Read More
